Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2000; 36:1152-1158
© 2000 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hammermeister, K.
Right arrow Articles by Rahimtoola, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammermeister, K.
Right arrow Articles by Rahimtoola, S. H.

Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial

Karl Hammermeister, MD, FACC*, Gulshan K. Sethi, MD, FACC{dagger}, William G. Henderson, PhD{ddagger}, Frederick L. Grover, MD, FACC*, Charles Oprian, PhD{ddagger} and Shahbudin H. Rahimtoola, MB, FRCP, MACP, MACC§

* Denver VA Medical Center and University of Colorado Health Sciences Center, Denver, Colorado, USA
{dagger} Tucson VA Medical Center and University of Arizona Health Sciences Center, Tucson, Arizona, USA
{ddagger} Hines VA Medical Center, Hines, Illinois, USA
§ LAC and USC Medical Center, University of Southern California, Los Angeles, California, USA



View larger version (27K):

[in a new window]
 
Figure 1 Death from any cause (including operative mortality). AVR = aortic valve replacement; MVR = mitral valve replacement.

 


View larger version (29K):

[in a new window]
 
Figure 2 Occurrence of one or more valve-related complications (bleeding, endocarditis, systemic embolism, nonthrombotic valve obstruction, valvular regurgitation or valve thrombosis). AVR = aortic valve replacement; MVR = mitral valve replacement.

 


View larger version (28K):

[in a new window]
 
Figure 3 One or more clinically significant bleed(s). AVR = aortic valve replacement; MVR = mitral valve replacement.

 


View larger version (29K):

[in a new window]
 
Figure 4 Primary valve failure (nonthrombotic valve obstruction or central valvular regurgitation). AVR = aortic valve replacement; MVR = mitral valve replacement.

 


View larger version (29K):

[in a new window]
 
Figure 5 Reoperation for any reason on randomized valve. AVR = aortic valve replacement; MVR = mitral valve replacement.

 


View larger version (22K):

[in a new window]
 
Figure 6 Primary valve failure among aortic valve replacement patients <65 and ≥65 years of age. AVR = aortic valve replacement; MVR = mitral valve replacement.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement